FRANKFURT, April 19 (Reuters) – Boehringer Ingelheim,
Germany’s second-largest drugmaker, posted 11 percent higher
sales and a 6 percent gain in operating profit for 2015, boosted
by its diabetes…
The post Boehringer’s operating profit up 6 percent on diabetes drugs appeared first on NASDAQ.